[1]
Keen, D.; Hadjikoumi, I. ADHD in children and adolescents BMJ
Clin. Evid, 2011, 2011, 0312.
[2]
APA; Diagnostic and statistical manual of mental disorders DSM-5., 5th ed.; American Psychiatric Association: Washington, DC. 2013.
[3]
Polanczyk, G.; de Lima, M.S.; Horta, B.L.; Biederman, J.; Rohde, L.A. The worldwide prevalence of ADHD: a systematic review and metaregression analysis. Am. J. Psychiatry, 2007, 164(6), 942-948.
[5]
De Sousa, A.; Kalra, G. Drug therapy of attention deficit hyperactivity disorder: Current trends. Mens Sana Monogr., 2012, 10(1), 45-69.
[6]
Shier, A.C.; Reichenbacher, T.; Ghuman, H.S.; Ghuman, J.K. Pharmacological treatment of attention deficit hyperactivity disorder in children and adolescents: Clinical strategies. J. Cent. Nerv. Syst. Dis., 2013, 5, 1-17.
[8]
Lange, K.W. The treatment of attention deficit hyperactivity disorder has no proven long-term benefits but possible adverse effects. Mov. Nutr. Health Dis., 2017, 1, 11-25.
[9]
Schweren, L.; Hoekstra, P.; van Lieshout, M.; Oosterlaan, J.; Lambregts-Rommelse, N.; Buitelaar, J.; Franke, B.; Hartman, C. Long-term effects of stimulant treatment on ADHD symptoms, social-emotional functioning, and cognition. Psychol. Med., 2018, 13, 1-7.
[10]
Howard, A.L.; Robinson, M.; Smith, G.J.; Ambrosini, G.L.; Piek, J.P.; Oddy, W.H. ADHD is associated with a “Western” dietary pattern in adolescents. J. Atten. Disord., 2011, 15(5), 403-411.
[11]
Kanarek, R.B. Artificial food dyes and attention deficit hyperactivity disorder. Nutr. Rev., 2011, 69(7), 385-391.
[12]
Hurt, E.A.; Arnold, L.E.; Lofthouse, N. Dietary and nutritional treatments for attention-deficit/hyperactivity disorder: Current research support and recommendations for practitioners. Curr. Psychiatry Rep., 2011, 13, 323-332.
[13]
Millichap, J.G.; Yee, M.M. The diet factor in attention-deficit/hyperactivity disorder. Pediatrics, 2012, 129, 330-337.
[14]
Heilskov Rytter, M.J.; Andersen, L.B.; Houmann, T.; Bilenberg, N.; Hvolby, A.; Mølgaard, C.; Michaelsen, K.F.; Lauritzen, L. Diet in the treatment of ADHD in children - a systematic review of the literature. Nord. J. Psychiatry, 2015, 69(1), 1-18.
[16]
Lange, K.W. Dietary factors in the etiology and therapy of attention deficit/hyperactivity disorder. Curr. Opin. Clin. Metab. Care, 2017, 20(6), 464-469.
[17]
Colter, A.L.; Cutler, C.; Meckling, K.A. Fatty acid status and behavioural symptoms of attention deficit hyperactivity disorder in adolescents: A case-control study. Nutr. J., 2008, 7, 8.
[18]
Schuchardt, J.P.; Huss, M.; Stauss-Grabo, M.; Hahn, A. Significance of long-chain polyunsaturated fatty acids (PUFAs) for the development and behaviour of children. Eur. J. Pediatr., 2010, 169, 149-164.
[19]
Frensham, L.J.; Bryan, J.; Parletta, N. Influences of micronutrient and omega-3 fatty acid supplementation on cognition, learning, and behavior: methodological considerations and implications for children and adolescents in developed societies. Nutr. Rev., 2012, 70, 594-610.
[20]
Johnson, M.; Månsson, J.E.; Ostlund, S.; Fransson, G.; Areskoug, B.; Hjalmarsson, K.; Landgren, M; Kadesjö, B.; Gillberg, C. Fatty
acids in ADHD: plasma profiles in a placebo-controlled study of
Omega 3/6 fatty acids in children and adolescents Atten. Defic.
Hyperact. Disord, 2012, 4(4), 199-204. ClinicalTrials.gov registration
number: NCT01219309.
[21]
Grant, R.; Guest, J. Role of omega-3 PUFAs in neurobiological health. Adv. Neurobiol., 2016, 12, 247-274.
[22]
Patterson, E.; Wall, R.; Fitzgerald, G.F.; Ross, R.P.; Stanton, C. Health Implications of High Dietary Omega-6 Polyunsaturated Fatty Acids. J. Nutr. Metab., 2012, 2012, 539426.
[23]
Bos, D.J.; van Montfort, S.J.T.; Oranje, B.; Durston, S.; Smeets, P.A. Role of omega-3 PUFAs in neurobiological health? Eur. Neuropsychopharmacol., 2016, 26, 546-561.
[24]
Raz, R.; Carasso, R.L.; Yehuda, S. The influence of short-chain essential fatty acids on children with attention-deficit/hyperactivity disorder: A double-blind placebo-controlled study. J. Child Adolesc. Psychopharmacol., 2009, 19, 167-177.
[25]
Perera, H.; Jeewandara, K.C.; Seneviratne, S.; Guruge, C. Combined ω3 and ω6 supplementation in children with attention-deficit hyperactivity disorder (ADHD) refractory to methylphenidate treatment: A double-blind, placebo-controlled study. J. Child Neurol., 2012, 27(6), 747-753.
[26]
Assareh, M.; Davari Ashtiani, R.; Khademi, M.; Jazayeri, S.; Rai, A.; Nikoo, M. Efficacy of Polyunsaturated Fatty Acids (PUFA) in the treatment of attention deficit hyperactivity disorder. J. Atten. Disord., 2012, 21(1), 78-85.
[27]
Manor, I.; Magen, A.; Keidar, D.; Rosen, S.; Tasker, H.; Cohen, T.; Richter, Y.; Zaaroor-Regev, D.; Manor, Y.; Weizman, A. The effect
of phosphatidylserine containing Omega3 fatty-acids on attention-
deficit hyperactivity disorder symptoms in children: a doubleblind
placebo-controlled trial, followed by an open-label extension Eur. Psychiat, 2012, 27(5), 335-342. ClinicalTrials.gov registration
number: NCT00418184.
[28]
Widenhorn-Müller, K.; Schwanda, S.; Scholz, E.; Spitzer, M.; Bode, H. Effect of supplementation with long-chain ω-3 polyunsaturated fatty acids on behavior and cognition in children with attention deficit/hyperactivity disorder (ADHD): A randomized placebo-controlled intervention trial. Prostaglandins Leukot. Essent. Fatty Acids, 2014, 91(1-2), 49-60.
[29]
Bos, D.J.; Oranje, B.; Veerhoek, E.S.; Van Diepen, R.M.; Weusten, J.M.; Demmelmair, H.; Koletzko, B. de Sain-var der Velden,
M.G.; Eilander, A.; Hoeksma, M.; Durston, S. Reduced symptoms
of inattention after dietary omega-3 fatty acid supplementation in
boys with and without attention deficit/hyperactivity disorder Neuropsychopharmacology, 2015, 40(10), 2298-2306. ClinicalTrials.
gov registration number: NCT01554462.
[30]
Groves, N.J.; Kesby, J.P.; Eyles, D.W.; McGrath, J.J.; Mackay-Sim, A.; Burne, T.H. Adult vitamin D deficiency leads to behavioural and brain neurochemical alterations in C57BL/6J and BALB/c mice. Behav. Brain Res., 2013, 241, 120-131.
[31]
Eyles, D.W.; Burne, T.H.; McGrath, J.J. Vitamin D, effects on brain development, adult brain function and the links between low levels of vitamin D and neuropsychiatric disease. Front. Neuroendocrinol., 2013, 34(1), 47-64.
[32]
Landaas, E.T.; Aarsland, T.I.M.; Ulvik, A.; Halmøy, A.; Ueland, P.M.; Haavik, J. Vitamin levels in adults with ADHD. BJPsych Open, 2016, 2(6), 377-384.
[33]
Kamal, M.; Bener, A.; Ehlayel, M.S. Is high prevalence of vitamin D deficiency a correlate for attention deficit hyperactivity disorder? Atten. Defic. Hyperact. Disord., 2014, 6(2), 73-78.
[34]
Goksugur, S.B.; Tufan, A.E.; Semiz, M. Gunes. C.; Bekdas, M.; Tosun, M.; Demircioglu, F. Vitamin D status in children with attention deficit hyperactivity disorder. Pediatr. Int., 2014, 56(4), 515-519.
[36]
Rucklidge, J.J.; Frampton, C.M.; Gorman, B.; Boggis, A. Vitaminmineral
treatment of attention-deficit hyperactivity disorder in
adults: double-blind randomised placebo-controlled trial Br J Psychiatry, 2014, 204, 306-315. Australian New Zealand Clinical Trials
Registry: ACTRN12609000308291.
[37]
Pelsser, L.M.; Frankena, K.; Toorman, J.; Savelkoul, H.F.; Dubois, A.E.; Pereira, R.R.; Haagen, T.A.; Rommelse, N.N.; Buitelaar, J.K. Effects of a restricted elimination diet on the behaviour of children
with attention-deficit hyperactivity disorder (INCA study): A randomised
controlled trial Lancet,, 2011, 377(9764), 494-503. International
Standard Randomised Controlled Trial, number ISRCTN
76063113.
[38]
Nigg, J.T.; Lewis, K.; Edinger, T.; Falk, M. Meta-analysis of attention- deficit/hyperactivity disorder or attention-deficit/hyperactivity disorder symptoms, restriction diet, and synthetic food color additives. J. Am. Acad. Child Adolesc. Psychiatry, 2012, 51(1), 86-97.e8.
[39]
Sonuga-Barke, E.J.; Brandeis, D.; Cortese, S.; Daley, D.; Ferrin, M.; Holtmann, M.; Stevenson, J.; Danckaerts, M.; van der Oord, S.; Döpfner, M.; Dittmann, R.W.; Simonoff, E.; Zuddas, A.; Banaschewski, T.; Buitelaar, J.; Coghill, D.; Hollis, C.; Konofal, E.; Lecendreux, M.; Wong, I.C.; Sergeant, J. European ADHD Guidelines Group. Nonpharmacological interventions for ADHD: Systematic review and meta-analyses of randomized controlled trials of dietary and psychological treatments. Am. J. Psychiatry, 2013, 170(3), 275-289.
[40]
Pelsser, L.M.; Frankena, K.; Toorman, J.; Savelkoul, H.F.; Pereira, R.R.; Buitelaar, J.K. A randomised controlled trial into the effects of food on ADHD. Eur. Child Adolesc. Psychiatry, 2009, 18(1), 12-19.
[41]
Donini, L.M.; Serra-Majem, L.; Bulló, M.; Gil, Á.; Salas-Salvadó, J. The Mediterranean diet: culture, health and science. Br. J. Nutr., 2015, 113(Suppl. 2), S1-S3.
[42]
Davis, C.; Bryan, J.; Hodgson, J.; Murphy, K. Definition of the Mediterranean diet: A literature review. Nutrients, 2015, 7(11), 9139-9153.
[43]
Ríos-Hernández, A.; Alda, J.A.; Farran-Codina, A.; Ferreira-García, E.; Izquierdo-Pulido, M. The Mediterranean diet and ADHD in children and adolescents. Pediatrics, 2017, 139(2)
[45]
Holton, K.F.; Nigg, J.T. The association of lifestyle factors and ADHD in children. J. Atten. Disord., 2016, 1087054716646452.
[46]
Zhou, F.; Wu, F.; Zou, S.; Chen, Y.; Feng, C.; Fan, G. Dietary, nutrient patterns and blood essential elements in chinese children with ADHD. Nutrients, 2016, 8, 352.
[47]
Holton, K.F.; Johnstone, J.M.; Brandley, E.T.; Nigg, J.T. Evaluation of dietary intake in children and college students with and without attention-deficit/hyperactivity disorder. Nutr. Neurosci., 2018, •••, 1-14.
[48]
Sinn, N.; Bryan, J.; Wilson, C. Cognitive effects of polyunsaturated fatty acids in children with attention deficit hyperactivity disorder symptoms: a randomised controlled trial. Prostaglandins Leukot. Essent. Fatty Acids, 2008, 78(4-5), 311-326.
[49]
Bélanger, S.A.; Vanasse, M.; Spahis, S.; Sylvestre, M.P.; Lippé, S.; L’heureux, F.; Ghadirian, P.; Vanasse, C.M.; Levy, E. Omega-3 fatty acid treatment of children with attention-deficit hyperactivity disorder: A randomized, double-blind, placebo-controlled study. Paediatr. Child Health, 2009, 14(2), 89-98.
[50]
Johnson, M.; Ostlund, S.; Fransson, G.; Kadesjö, B.; Gillberg, C. Omega-3/omega-6 fatty acids for attention deficit hyperactivity disorder: a randomized placebo-controlled trial in children and adolescents. J. Atten. Disord., 2009, 12(5), 394-401.
[51]
Kirby, A.; Woodward, A.; Jackson, S.; Wang, Y.; Crawford, M.A. A double-blind, placebo-controlled study investigating the effects of omega-3 supplementation in children aged 8-10 years from a mainstream school population. Res. Dev. Disabil., 2010, 31(3), 718-730.
[52]
Milte, C.M.; Parletta, N.; Buckley, J.D.; Coates, A.M.; Young, R.M.; Howe, P.R. Eicosapentaenoic and docosahexaenoic acids, cognition, and behavior in children with attention-deficit/ hyperactivity disorder: A randomized controlled trial. Nutrition, 2012, 28(6), 670-677.
[53]
Gustafsson, P.A.; Birberg-Thornberg, U.; Duchén, K.; Landgren, M.; Malmberg, K.; Pelling, H.; Strandvik, B.; Karlsson, T. EPA supplementation improves teacher-rated behaviour and oppositional symptoms in children with ADHD. Acta Paediatr., 2010, 99(10), 1540-1549.
[54]
Bloch, M.H.; Qawasmi, A. Omega-3 fatty acid supplementation for the treatment of children with attention-deficit/hyperactivity disorder symptomatology: Systematic review and meta-analysis. J. Am. Acad. Child Adolesc. Psychiatry, 2011, 50(10), 991-1000.
[55]
Holick, M.F.; Binkley, N.C.; Bischoff-Ferrari, H.A.; Gordon, C.M.; Hanley, D.A.; Heaney, R.P.; Murad, M.H.; Weaver, C.M. Endocrine Society. Evaluation, treatment, and prevention of vitamin D deficiency: An Endocrine Society clinical practice guideline. J. Clin. Endocrinol. Metab., 2011, 96(7), 1911-1930.
[56]
Sharif, M.R.; Madani, M.; Tabatabaei, F.; Tabatabaee, Z. The relationship between serum vitamin D level and attention deficit hyperactivity disorder. Iran. J. Child. Neurol., 2015, 9(4), 48-53.
[57]
Shang-Guan, L.L.; Zhao, Y.R. Serum levels of 25-hydroxyvitamin D in children with attention deficit hyperactivity disorder. Zhongguo Dang Dai Er Ke Za Zhi, 2015, 17(8), 837-840.
[58]
Tolppanen, A.M.; Sayers, A.; Fraser, W.; Lewis, G.; Zammit, S.; Lawlor, D.A. The association of 25-hydroxyvitamin D3 and D2 with behavioural problems in childhood. PLoS One, 2012, 7(7), e40097.
[59]
Rucklidge, J.J.; Johnstone, J.; Gorman, B.; Boggis, A.; Frampton, C.M. Moderators of treatment response in adults with ADHD treated with a vitamin-mineral supplement. Prog. Neuropsychopharmacol. Biol. Psychiatry, 2014, 50, 163-171.
[60]
Kim, Y.; Chang, H. Correlation between attention deficit hyperactivity disorder and sugar consumption, quality of diet, and dietary behavior in school children. Nutr. Res. Pract., 2011, 5(3), 236-245.
[61]
Park, S.; Cho, S.C.; Hong, Y.C.; Oh, S.Y.; Kim, J.W.; Shin, M.S.; Kim, B.N.; Yoo, H.J.; Cho, I.H.; Bhang, S.Y. Association between dietary behaviors and attention-deficit/hyperactivity disorder and learning disabilities in school-aged children. Psychiatry Res., 2012, 198(3), 468-476.
[62]
Azadbakht, L.; Esmaillzadeh, A. Dietary patterns and attention deficit hyperactivity disorder among Iranian children. Nutrition, 2012, 28(3), 242-249.
[63]
Woo, H.D.; Kim, D.W.; Hong, Y.S.; Kim, Y.M.; Seo, J.H.; Choe, B.M.; Park, J.H.; Kang, J.W.; Yoo, J.H.; Chueh, H.W.; Lee, J.H.; Kwak, M.J.; Kim, J. Dietary patterns in children with Attention Deficit/Hyperactivity Disorder (ADHD). Nutrients, 2014, 6(4), 1539-1553.